Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPageGroup Regulatory News (PAGE)

Share Price Information for PageGroup (PAGE)

Share Price is delayed by 15 minutes
Get Live Data
125.20    -0.60 (-0.48%)
Bid:
124.10
Ask:
125.20
Spread: 1.10 (0.886%)
Market Cap: £389.83m
PAGE Live PriceLast checked at - London Stock Exchange

Intraday PageGroup Share Chart

Director/PDMR Shareholding

16 Mar 2009 17:29

RNS Number : 9497O
Michael Page International PLC
16 March 2009
 



Michael Page International plc 13 March 2009

Notification of Director's Interests in Shares

Release of shares under the Michael Page Annual Bonus Plan

On 9 March 2009UBS Trustees (Jersey) Limited, the trustee of the Michael Page Employees' Benefit Trust ("EBT") transferred the legal title of the number of Michael Page International plc ordinary shares of 1p each ("Shares") set out in the table below, to the Executive Directors of Michael Page International plc (the "Company"), for nil cost, as a result of the vesting of their allocations under the Annual Bonus Plan. Of these, the trustee of the EBT arranged for the sale of sufficient of such Shares on behalf of the Executive Directors at 188.22 pence per Share on 9 March 2009 in order to reimburse the Company for their personal tax and social security liabilities arising together with such number of additional Shares that each Executive Director has notified to the trustee that he would like to sell.

The number of Shares sold and transferred is set out below.

Executive Director

Total no of Shares transferred on 9 March 2009

Shares sold on 9 March 2009

Net no of Shares transferred on 9 March 2009

S Ingham

324,018

133,779

190,239

S Puckett

268,793

110,978

157,815

C-H Dumon

392,164

250,000

142,164

Release of Shares under the Michael Page Incentive Share Plan

In addition, on 9 March 2009, the trustee of the EBT transferred the legal title of the number of Shares set out in the table below, to the Executive Directors and persons discharging managerial responsibilities ("PDMR") of the Company, for nil cost, as a result of the vesting of their allocations under the Incentive Share Plan. Of these, the trustee of the EBT arranged for the sale of sufficient of such Shares on behalf of the Executive Directors and PDMRs at 188.22 pence per Share on 9 March 2009 in order to reimburse the Company for their personal tax and social security liabilities arising together with such number of additional Shares that each Executive Director and PDMR has notified to the trustee that he would like to sell.

  The number of Shares sold and transferred is set out below.

Executive Director / PDMR

Total no of Shares transferred on 9 March 2009

Shares sold on  9 March 2009

Net no of Shares transferred on 9 March 2009

S Ingham (1)

102,200

42,199

60,001

S Puckett (1)

102,200

42,199

60,001

C-H Dumon (1)

194,946

-

194,946

G James (2)

39,120

2,567

36,553

A de Bretteville (2)

48,900

14,234

34,666

(1) Executive Director

(2) PDMR

This announcement is made in accordance with DR 3.1.4 R(1)(a) and DR 3.1.4 R(1)(c).

Michael Page International plc

Kelvin Stagg, Company Secretary 01932 264141

Financial Dynamics

Richard Mountain 020 7269 7291

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSFAFWMSUSEED
Date   Source Headline
28th May 20261:22 pmRNSResult of AGM
7th May 20263:00 pmRNSBoard change
14th Apr 20267:00 amRNSFIRST QUARTER 2026 TRADING UPDATE
13th Apr 202610:51 amRNSAnnual Report & Accounts & Notice of AGM
10th Apr 202612:34 pmRNSNotice of First Quarter 2026 Trading Update
30th Mar 20261:51 pmRNSDirector/PDMR Shareholding
19th Mar 20269:18 amRNSHolding(s) in Company
17th Mar 20269:44 amRNSDirector/PDMR Shareholding
16th Mar 202611:34 amRNSDirector/PDMR Shareholding
16th Mar 202611:34 amRNSDirector/PDMR Shareholding
13th Mar 20261:32 pmRNSDirector/PDMR Shareholding
9th Mar 20269:21 amRNSHolding(s) in Company
5th Mar 20261:22 pmRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSFull Year Results for the Year Ended 31 Dec 2025
4th Mar 202611:43 amRNSPageGroup plc - Board Changes
2nd Mar 20262:58 pmRNSNotice of 2025 Full Year Results
17th Feb 202612:50 pmRNSHolding(s) in Company
10th Feb 20263:55 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNSFOURTH QUARTER 2025 TRADING UPDATE
9th Jan 202610:23 amRNSNotice of Q4 and Full Year 2025 Trading Update
17th Dec 20252:17 pmRNSHolding(s) in Company
26th Nov 20259:38 amRNSHolding(s) in Company
24th Oct 202511:31 amRNSHolding(s) in Company
15th Oct 20257:00 amRNSTHIRD QUARTER 2025 TRADING UPDATE
13th Oct 202511:03 amRNSNotice of Third Quarter 2025 Trading Update
8th Oct 202511:31 amRNSHolding(s) in Company
12th Aug 20257:00 amRNSHalf Year Results for the Period Ended 30 June 25
7th Aug 20259:58 amRNSNotice of 2025 Half Year Results
10th Jul 20257:00 amRNSSecond Quarter 2025 Trading Update
8th Jul 20255:03 pmRNSNotice of Second Quarter 2025 Trading Update
11th Jun 202511:45 amRNSPageGroup plc - Board Changes
9th Jun 20254:11 pmRNSHolding(s) in Company
5th Jun 20257:00 amRNSAppointment of Joint Corporate Broker
4th Jun 202510:56 amRNSHolding(s) in Company
3rd Jun 20251:57 pmRNSResult of AGM
9th Apr 20257:00 amRNSFirst Quarter 2025 Trading Update
24th Mar 20252:02 pmRNSDirector Declaration
19th Mar 20251:18 pmRNSHolding(s) in Company
18th Mar 20251:41 pmRNSDirector/PDMR Shareholding
18th Mar 20251:35 pmRNSDirector/PDMR Shareholding
14th Mar 20251:10 pmRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSFull Year Results for the Year Ended 31 Dec 2024
4th Mar 20259:40 amRNSNotice of 2024 Full Year Results
6th Feb 20259:44 amRNSDirector/PDMR Shareholding
13th Jan 20257:00 amRNSFourth Quarter 2024 Trading Update
9th Jan 20254:25 pmRNSNotice of Q4 and Full Year 2024 Trading Update
31st Oct 20243:37 pmRNSNotification of Interests of Directors
14th Oct 20247:00 amRNSThird Quarter 2024 Trading Update
10th Oct 202411:50 amRNSNotice of Third Quarter 2024 Trading Update
8th Aug 20247:00 amRNSHalf Year Results for the Period Ended 30 June 24

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.